Officer received an award of 735 TECH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 2, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 4, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000914190-26-000036
- Filed / recorded
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly Reporting personSteven C. Crouse Officer titlePresident - Diag & Spatial Bi SecurityRestricted Stock Units TableDerivative (Table II) Transaction dateMar 2, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- 245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.
Around the same time
April McClain Delaney soldDemocrat, Representative, MD district 6D · MD-6Held by the filer's dependent child per the disclosure. Disclosed 14 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.